Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
AngioSoma, Inc.
AngioSoma and its Subsidiary SomaCeuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
11 févr. 2021 10h42 HE
|
AngioSoma, Inc.
Houston, TX, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”), through its wholly-owned subsidiary, SomaCeuticals, Inc., is pleased to...
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
08 déc. 2020 09h30 HE
|
AngioSoma, Inc.
Houston, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s subsidiary, SomaCeuticals, Inc.,...
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
24 août 2020 12h10 HE
|
AngioSoma, Inc.
Houston, TX, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the company’s subsidiary, SomaCeuticals,...
SomaCeuticals Elects New President
17 août 2020 10h45 HE
|
AngioSoma, Inc.
Houston, TX, Aug. 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the company’s subsidiary, SomaCeuticals,...
AngioSoma Focusing on Development of Coating for Metal Stents
27 mai 2020 10h42 HE
|
AngioSoma, Inc.
Houston, TX, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company is focusing on development and...
AngioSoma's Development of Atherectomy Catheter
20 mai 2020 09h54 HE
|
AngioSoma, Inc.
Houston, TX, May 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s peripheral arterial disease...
AngioSoma Continues to Liquidate Debt
21 avr. 2020 09h53 HE
|
AngioSoma, Inc.
Houston, TX, April 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced that holders of the Company's 12% unsecured convertible...
AngioSoma Moving Forward With Exciting New Products
09 mars 2020 11h10 HE
|
AngioSoma, Inc.
Houston, TX, March 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced creating an innovative marketing strategy for its 15...
AngioSoma Announces Trademark Allowed for Muscles4U
22 janv. 2020 09h30 HE
|
AngioSoma, Inc.
Houston, TX, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that we have received official notice of allowance...
AngioSoma Acquires Technology Related to 15 Patents
15 janv. 2020 09h30 HE
|
AngioSoma, Inc.
Houston, Jan. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that we have acquired the unconditional ownership of...